Binu V John
Overview
Explore the profile of Binu V John including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
John B, Bastaich D, Mezzacappa C, Ferreira R, Hentschel A, Samos A, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 39950372
Introduction: Although metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) are identified as clinical entities; tools to identify patients from electronic health records (EHRs) to...
2.
Wong R, Yang Z, Jou J, John B, Lim J, Cheung R
Gastro Hep Adv
. 2025 Feb;
4(3):100575.
PMID: 39906477
Background And Aims: Hepatitis delta virus (HDV) infection in patients with chronic hepatitis B (CHB) is associated with worse liver-related outcomes. We aim to comprehensively evaluate HDV testing, diagnosis, and...
3.
Njei B, Mezzacappa C, John B, Serper M, Kaplan D, Taddei T, et al.
Dig Dis Sci
. 2025 Jan;
70(2):802-813.
PMID: 39779587
Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has a global prevalence of 25%. Studies on incident liver and cardiovascular outcomes in lean (Body mass index: BMI < 25 ...
4.
Mezzacappa C, Ochoa-Allemant P, Serper M, Taddei T, John B, Kaplan D, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39689774
Background & Aims: Novel steatotic liver disease (SLD) definitions were introduced in 2023. Accurate and meaningful classifications using clinical data are needed to study interventions and outcomes. Methods: In a...
5.
6.
7.
8.
John B, Bastaich D, Dahman B
Pharmacoepidemiol Drug Saf
. 2024 Oct;
33(10):e70013.
PMID: 39415072
Background: The accuracy of administrative codes to capture patients with both primary biliary cholangitis (PBC) and cirrhosis could be challenging because of the potential for incorrect coding due to the...
9.
John B, Bastaich D, Amoli M, Wong R, Evon D, Rogal S, et al.
Hepatology
. 2024 Sep;
PMID: 39255517
Background: Hepatitis Delta Virus (HDV) infection is the most severe form of chronic hepatitis. However, studies on outcomes and causes of death in a United States-born population, with primarily horizontal...
10.
John B, Amoli M, Evon D, Wong R, Dahman B
Hepatol Commun
. 2024 Apr;
8(5).
PMID: 38619425
Background: The low prevalence of HDV infection in the United States could be attributed to insufficient testing rate, which can result in an underestimation of the true burden of HDV....